Self-administered intranasal medication to terminate supraventricular tachycardia
- PMID: 37331367
- DOI: 10.1016/S0140-6736(23)00823-1
Self-administered intranasal medication to terminate supraventricular tachycardia
Conflict of interest statement
SK has received research grants from Abbott Medical and Biotronik and speaker's honoraria from Biosense Webster, Abbott Medical, Biotronik, and Sanofi Aventis. TC has received speaker's honoraria from Biosense Webster.
Comment on
-
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.J Am Coll Cardiol. 2018 Jul 31;72(5):489-497. doi: 10.1016/j.jacc.2018.04.082. J Am Coll Cardiol. 2018. PMID: 30049309 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources